APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tubular Injection Vial

Compare research editions
View pricing & licenses

Selected research

Industry Research

Tubular Injection Vial Industry Research Report 2026

5 June 2026150 pages

Choose your research edition.

Industry ResearchTubular Injection Vial Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Tubular Injection Vial Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Tubular Injection Vial Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tubular Injection Vial Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Tubular Injection Vial Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Tubular Injection Vial market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Tubular Injection Vial is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Tubular Injection Vial is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Tubular Injection Vial is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Tubular Injection Vial include SGD, SCHOTT Pharma, Gerresheimer AG, DWK Life Sciences, Stevanato Group, Corning, Nipro Corporation, Daikyo Seiko and West Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Tubular Injection Vial market in terms of revenue (US$ million) and, where applicable, sales volume (M units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Tubular Injection Vial Market by Company

SGD

SCHOTT Pharma

Gerresheimer AG

DWK Life Sciences

Stevanato Group

Corning

Nipro Corporation

Daikyo Seiko

West Pharmaceutical

Radpharm Scientific

Pacific Vial Manufacturing

Ningbo Zhengli Pharmaceutical Packaging

Linuo Pharmaceutical Packaging

Chongqing Zhengchuan Pharmaceutical Packaging

Shandong Pharmaceutical Glass

CANGZHOU FOUR STARS GLASS

Anhui Huaxin Pharmaceutical Glass Products

Jiyuan Zhengyu Industrial

Taian Youlyy Industrial

Nantong Xinde Medical Packing Material

Chengdu Jingu Medicinal Packing

Tubular Injection Vial Segment by Type

Low Borosilicate Tubular Injection Vial

Medium Borosilicate Tubular Injection Vial

High Borosilicate Tubular Injection Vial

Soda-lime Tubular Injection Vial

Tubular Injection Vial Segment by Application

Biologicals

Lyophilized Powder Injection

Vaccines

Other

Tubular Injection Vial Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tubular Injection Vial market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tubular Injection Vial and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tubular Injection Vial.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Tubular Injection Vial manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Tubular Injection Vial by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Tubular Injection Vial in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Tubular Injection Vial Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Tubular Injection Vial Sales (M units) of Manufacturers (2021-2026) Table 7. Global Tubular Injection Vial Sales Market Share by Manufacturers (2021-2026) Table 8. Global Tubular Injection Vial Revenue of Manufacturers (2021-2026) Table 9. Global Tubular Injection Vial Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Tubular Injection Vial Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Tubular Injection Vial Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Tubular Injection Vial, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Tubular Injection Vial, Product Type & Application Table 14. Global Tubular Injection Vial Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Tubular Injection Vial by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. SGD Company Information Table 19. SGD Business Overview Table 20. SGD Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. SGD Tubular Injection Vial Product Portfolio Table 22. SGD Recent Developments Table 23. SCHOTT Pharma Company Information Table 24. SCHOTT Pharma Business Overview Table 25. SCHOTT Pharma Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. SCHOTT Pharma Tubular Injection Vial Product Portfolio Table 27. SCHOTT Pharma Recent Developments Table 28. Gerresheimer AG Company Information Table 29. Gerresheimer AG Business Overview Table 30. Gerresheimer AG Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. Gerresheimer AG Tubular Injection Vial Product Portfolio Table 32. Gerresheimer AG Recent Developments Table 33. DWK Life Sciences Company Information Table 34. DWK Life Sciences Business Overview Table 35. DWK Life Sciences Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. DWK Life Sciences Tubular Injection Vial Product Portfolio Table 37. DWK Life Sciences Recent Developments Table 38. Stevanato Group Company Information Table 39. Stevanato Group Business Overview Table 40. Stevanato Group Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. Stevanato Group Tubular Injection Vial Product Portfolio Table 42. Stevanato Group Recent Developments Table 43. Corning Company Information Table 44. Corning Business Overview Table 45. Corning Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Corning Tubular Injection Vial Product Portfolio Table 47. Corning Recent Developments Table 48. Nipro Corporation Company Information Table 49. Nipro Corporation Business Overview Table 50. Nipro Corporation Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. Nipro Corporation Tubular Injection Vial Product Portfolio Table 52. Nipro Corporation Recent Developments Table 53. Daikyo Seiko Company Information Table 54. Daikyo Seiko Business Overview Table 55. Daikyo Seiko Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. Daikyo Seiko Tubular Injection Vial Product Portfolio Table 57. Daikyo Seiko Recent Developments Table 58. West Pharmaceutical Company Information Table 59. West Pharmaceutical Business Overview Table 60. West Pharmaceutical Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. West Pharmaceutical Tubular Injection Vial Product Portfolio Table 62. West Pharmaceutical Recent Developments Table 63. Radpharm Scientific Company Information Table 64. Radpharm Scientific Business Overview Table 65. Radpharm Scientific Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Radpharm Scientific Tubular Injection Vial Product Portfolio Table 67. Radpharm Scientific Recent Developments Table 68. Pacific Vial Manufacturing Company Information Table 69. Pacific Vial Manufacturing Business Overview Table 70. Pacific Vial Manufacturing Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Pacific Vial Manufacturing Tubular Injection Vial Product Portfolio Table 72. Pacific Vial Manufacturing Recent Developments Table 73. Ningbo Zhengli Pharmaceutical Packaging Company Information Table 74. Ningbo Zhengli Pharmaceutical Packaging Business Overview Table 75. Ningbo Zhengli Pharmaceutical Packaging Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Ningbo Zhengli Pharmaceutical Packaging Tubular Injection Vial Product Portfolio Table 77. Ningbo Zhengli Pharmaceutical Packaging Recent Developments Table 78. Linuo Pharmaceutical Packaging Company Information Table 79. Linuo Pharmaceutical Packaging Business Overview Table 80. Linuo Pharmaceutical Packaging Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Linuo Pharmaceutical Packaging Tubular Injection Vial Product Portfolio Table 82. Linuo Pharmaceutical Packaging Recent Developments Table 83. Chongqing Zhengchuan Pharmaceutical Packaging Company Information Table 84. Chongqing Zhengchuan Pharmaceutical Packaging Business Overview Table 85. Chongqing Zhengchuan Pharmaceutical Packaging Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Chongqing Zhengchuan Pharmaceutical Packaging Tubular Injection Vial Product Portfolio Table 87. Chongqing Zhengchuan Pharmaceutical Packaging Recent Developments Table 88. Shandong Pharmaceutical Glass Company Information Table 89. Shandong Pharmaceutical Glass Business Overview Table 90. Shandong Pharmaceutical Glass Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Shandong Pharmaceutical Glass Tubular Injection Vial Product Portfolio Table 92. Shandong Pharmaceutical Glass Recent Developments Table 93. CANGZHOU FOUR STARS GLASS Company Information Table 94. CANGZHOU FOUR STARS GLASS Business Overview Table 95. CANGZHOU FOUR STARS GLASS Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. CANGZHOU FOUR STARS GLASS Tubular Injection Vial Product Portfolio Table 97. CANGZHOU FOUR STARS GLASS Recent Developments Table 98. Anhui Huaxin Pharmaceutical Glass Products Company Information Table 99. Anhui Huaxin Pharmaceutical Glass Products Business Overview Table 100. Anhui Huaxin Pharmaceutical Glass Products Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Anhui Huaxin Pharmaceutical Glass Products Tubular Injection Vial Product Portfolio Table 102. Anhui Huaxin Pharmaceutical Glass Products Recent Developments Table 103. Jiyuan Zhengyu Industrial Company Information Table 104. Jiyuan Zhengyu Industrial Business Overview Table 105. Jiyuan Zhengyu Industrial Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Jiyuan Zhengyu Industrial Tubular Injection Vial Product Portfolio Table 107. Jiyuan Zhengyu Industrial Recent Developments Table 108. Taian Youlyy Industrial Company Information Table 109. Taian Youlyy Industrial Business Overview Table 110. Taian Youlyy Industrial Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Taian Youlyy Industrial Tubular Injection Vial Product Portfolio Table 112. Taian Youlyy Industrial Recent Developments Table 113. Nantong Xinde Medical Packing Material Company Information Table 114. Nantong Xinde Medical Packing Material Business Overview Table 115. Nantong Xinde Medical Packing Material Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Nantong Xinde Medical Packing Material Tubular Injection Vial Product Portfolio Table 117. Nantong Xinde Medical Packing Material Recent Developments Table 118. Chengdu Jingu Medicinal Packing Company Information Table 119. Chengdu Jingu Medicinal Packing Business Overview Table 120. Chengdu Jingu Medicinal Packing Tubular Injection Vial Sales (M units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Chengdu Jingu Medicinal Packing Tubular Injection Vial Product Portfolio Table 122. Chengdu Jingu Medicinal Packing Recent Developments Table 123. Global Tubular Injection Vial Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 124. Global Tubular Injection Vial Sales by Region (2021-2026) & (M units) Table 125. Global Tubular Injection Vial Sales Market Share by Region (2021-2026) Table 126. Global Tubular Injection Vial Sales by Region (2027-2032) & (M units) Table 127. Global Tubular Injection Vial Sales Market Share by Region (2027-2032) Table 128. Global Tubular Injection Vial Revenue by Region (2021-2026) & (US$ Million) Table 129. Global Tubular Injection Vial Revenue Market Share by Region (2021-2026) Table 130. Global Tubular Injection Vial Revenue by Region (2027-2032) & (US$ Million) Table 131. Global Tubular Injection Vial Revenue Market Share by Region (2027-2032) Table 132. North America Tubular Injection Vial Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. North America Tubular Injection Vial Sales by Country (2021-2026) & (M units) Table 134. North America Tubular Injection Vial Sales by Country (2027-2032) & (M units) Table 135. North America Tubular Injection Vial Revenue by Country (2021-2026) & (US$ Million) Table 136. North America Tubular Injection Vial Revenue by Country (2027-2032) & (US$ Million) Table 137. Europe Tubular Injection Vial Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Europe Tubular Injection Vial Sales by Country (2021-2026) & (M units) Table 139. Europe Tubular Injection Vial Sales by Country (2027-2032) & (M units) Table 140. Europe Tubular Injection Vial Revenue by Country (2021-2026) & (US$ Million) Table 141. Europe Tubular Injection Vial Revenue by Country (2027-2032) & (US$ Million) Table 142. Asia Pacific Tubular Injection Vial Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Asia Pacific Tubular Injection Vial Sales by Country (2021-2026) & (M units) Table 144. Asia Pacific Tubular Injection Vial Sales by Country (2027-2032) & (M units) Table 145. Asia Pacific Tubular Injection Vial Revenue by Country (2021-2026) & (US$ Million) Table 146. Asia Pacific Tubular Injection Vial Revenue by Country (2027-2032) & (US$ Million) Table 147. South America Tubular Injection Vial Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. South America Tubular Injection Vial Sales by Country (2021-2026) & (M units) Table 149. South America Tubular Injection Vial Sales by Country (2027-2032) & (M units) Table 150. South America Tubular Injection Vial Revenue by Country (2021-2026) & (US$ Million) Table 151. South America Tubular Injection Vial Revenue by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Tubular Injection Vial Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Middle East and Africa Tubular Injection Vial Sales by Country (2021-2026) & (M units) Table 154. Middle East and Africa Tubular Injection Vial Sales by Country (2027-2032) & (M units) Table 155. Middle East and Africa Tubular Injection Vial Revenue by Country (2021-2026) & (US$ Million) Table 156. Middle East and Africa Tubular Injection Vial Revenue by Country (2027-2032) & (US$ Million) Table 157. Global Tubular Injection Vial Sales by Type (2021-2026) & (M units) Table 158. Global Tubular Injection Vial Sales by Type (2027-2032) & (M units) Table 159. Global Tubular Injection Vial Sales Market Share by Type (2021-2026) Table 160. Global Tubular Injection Vial Sales Market Share by Type (2027-2032) Table 161. Global Tubular Injection Vial Revenue by Type (2021-2026) & (US$ Million) Table 162. Global Tubular Injection Vial Revenue by Type (2027-2032) & (US$ Million) Table 163. Global Tubular Injection Vial Revenue Market Share by Type (2021-2026) Table 164. Global Tubular Injection Vial Revenue Market Share by Type (2027-2032) Table 165. Global Tubular Injection Vial Price by Type (2021-2026) & (USD/unit) Table 166. Global Tubular Injection Vial Price by Type (2027-2032) & (USD/unit) Table 167. Global Tubular Injection Vial Sales by Application (2021-2026) & (M units) Table 168. Global Tubular Injection Vial Sales by Application (2027-2032) & (M units) Table 169. Global Tubular Injection Vial Sales Market Share by Application (2021-2026) Table 170. Global Tubular Injection Vial Sales Market Share by Application (2027-2032) Table 171. Global Tubular Injection Vial Revenue by Application (2021-2026) & (US$ Million) Table 172. Global Tubular Injection Vial Revenue by Application (2027-2032) & (US$ Million) Table 173. Global Tubular Injection Vial Revenue Market Share by Application (2021-2026) Table 174. Global Tubular Injection Vial Revenue Market Share by Application (2027-2032) Table 175. Global Tubular Injection Vial Price by Application (2021-2026) & (USD/unit) Table 176. Global Tubular Injection Vial Price by Application (2027-2032) & (USD/unit) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Tubular Injection Vial Distributors List Table 180. Tubular Injection Vial Customers List Table 181. Tubular Injection Vial Industry Trends Table 182. Tubular Injection Vial Industry Drivers Table 183. Tubular Injection Vial Industry Restraints Table 184. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Tubular Injection Vial Product Image Figure 5. Global Tubular Injection Vial Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Tubular Injection Vial Market Size (2021-2032) & (US$ Million) Figure 7. Global Tubular Injection Vial Sales (2021-2032) & (M units) Figure 8. Global Tubular Injection Vial Average Price (USD/unit) & (2021-2032) Figure 9. Low Borosilicate Tubular Injection Vial Product Image Figure 10. Medium Borosilicate Tubular Injection Vial Product Image Figure 11. High Borosilicate Tubular Injection Vial Product Image Figure 12. Soda-lime Tubular Injection Vial Product Image Figure 13. Biologicals Product Image Figure 14. Lyophilized Powder Injection Product Image Figure 15. Vaccines Product Image Figure 16. Other Product Image Figure 17. Global Tubular Injection Vial Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Tubular Injection Vial, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Tubular Injection Vial Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Tubular Injection Vial Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Tubular Injection Vial Sales by Region in 2025 Figure 23. Global Tubular Injection Vial Revenue by Region in 2025 Figure 24. North America Tubular Injection Vial Market Size by Country in 2025 Figure 25. North America Tubular Injection Vial Sales Market Share by Country (2021-2032) Figure 26. North America Tubular Injection Vial Revenue Market Share by Country (2021-2032) Figure 27. United States Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Tubular Injection Vial Market Size by Country in 2025 Figure 31. Europe Tubular Injection Vial Sales Market Share by Country (2021-2032) Figure 32. Europe Tubular Injection Vial Revenue Market Share by Country (2021-2032) Figure 33. Germany Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Tubular Injection Vial Market Size by Country in 2025 Figure 44. Asia Pacific Tubular Injection Vial Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Tubular Injection Vial Revenue Market Share by Country (2021-2032) Figure 46. China Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Tubular Injection Vial Market Size by Country in 2025 Figure 55. South America Tubular Injection Vial Sales Market Share by Country (2021-2032) Figure 56. South America Tubular Injection Vial Revenue Market Share by Country (2021-2032) Figure 57. Brazil Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Tubular Injection Vial Market Size by Country in 2025 Figure 61. Middle East and Africa Tubular Injection Vial Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Tubular Injection Vial Revenue Market Share by Country (2021-2032) Figure 63. Egypt Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Tubular Injection Vial Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Tubular Injection Vial Sales Market Share by Type (2021-2032) Figure 69. Global Tubular Injection Vial Revenue Market Share by Type (2021-2032) Figure 70. Global Tubular Injection Vial Price (USD/unit) by Type (2021-2032) Figure 71. Global Tubular Injection Vial Sales Market Share by Application (2021-2032) Figure 72. Global Tubular Injection Vial Revenue Market Share by Application (2021-2032) Figure 73. Global Tubular Injection Vial Price (USD/unit) by Application (2021-2032) Figure 74. Tubular Injection Vial Value Chain Figure 75. Tubular Injection Vial Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Tubular Injection Vial Industry Opportunities and Challenges

Scope & coverage.

Types
  • Low Borosilicate Tubular Injection Vial
  • Medium Borosilicate Tubular Injection Vial
  • High Borosilicate Tubular Injection Vial
  • Soda-lime Tubular Injection Vial
Applications
  • Biologicals
  • Lyophilized Powder Injection
  • Vaccines
  • Other
Companies covered
  • SGD
  • SCHOTT Pharma
  • Gerresheimer AG
  • DWK Life Sciences
  • Stevanato Group
  • Corning
  • Nipro Corporation
  • Daikyo Seiko
  • West Pharmaceutical
  • Radpharm Scientific
  • Pacific Vial Manufacturing
  • Ningbo Zhengli Pharmaceutical Packaging
  • Linuo Pharmaceutical Packaging
  • Chongqing Zhengchuan Pharmaceutical Packaging
  • Shandong Pharmaceutical Glass
  • CANGZHOU FOUR STARS GLASS
  • Anhui Huaxin Pharmaceutical Glass Products
  • Jiyuan Zhengyu Industrial
  • Taian Youlyy Industrial
  • Nantong Xinde Medical Packing Material
  • Chengdu Jingu Medicinal Packing

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Tubular Injection Vial Market Size (2021-2032)
  4. 2.2.2 Global Tubular Injection Vial Sales (2021-2032)
  5. 2.2.3 Global Tubular Injection Vial Market Average Price (2021-2032)
  6. 2.3 Tubular Injection Vial by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Low Borosilicate Tubular Injection Vial
  9. 2.3.3 Medium Borosilicate Tubular Injection Vial
  10. 2.3.4 High Borosilicate Tubular Injection Vial
  11. 2.3.5 Soda-lime Tubular Injection Vial
  12. 2.4 Tubular Injection Vial by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Biologicals
  15. 2.4.3 Lyophilized Powder Injection
  16. 2.4.4 Vaccines
  17. 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Tubular Injection Vial Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Tubular Injection Vial Sales (M units) of Manufacturers (2021-2026)
  3. 3.3 Global Tubular Injection Vial Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Tubular Injection Vial Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Tubular Injection Vial Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Tubular Injection Vial, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Tubular Injection Vial, Product Type & Application
  8. 3.8 Global Manufacturers of Tubular Injection Vial, Established Date
  9. 3.9 Global Tubular Injection Vial Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 SGD
  2. 4.1.1 SGD Company Information
  3. 4.1.2 SGD Business Overview
  4. 4.1.3 SGD Tubular Injection Vial Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 SGD Tubular Injection Vial Product Portfolio
  6. 4.1.5 SGD Recent Developments
  7. 4.2 SCHOTT Pharma
  8. 4.2.1 SCHOTT Pharma Company Information
  9. 4.2.2 SCHOTT Pharma Business Overview
  10. 4.2.3 SCHOTT Pharma Tubular Injection Vial Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 SCHOTT Pharma Tubular Injection Vial Product Portfolio
  12. 4.2.5 SCHOTT Pharma Recent Developments
  13. 4.3 Gerresheimer AG
  14. 4.3.1 Gerresheimer AG Company Information
  15. 4.3.2 Gerresheimer AG Business Overview
  16. 4.3.3 Gerresheimer AG Tubular Injection Vial Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Gerresheimer AG Tubular Injection Vial Product Portfolio
  18. 4.3.5 Gerresheimer AG Recent Developments
  19. 4.4 DWK Life Sciences
  20. 4.4.1 DWK Life Sciences Company Information
  21. 4.4.2 DWK Life Sciences Business Overview
  22. 4.4.3 DWK Life Sciences Tubular Injection Vial Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 DWK Life Sciences Tubular Injection Vial Product Portfolio
  24. 4.4.5 DWK Life Sciences Recent Developments
  25. 4.5 Stevanato Group
  26. 4.5.1 Stevanato Group Company Information
  27. 4.5.2 Stevanato Group Business Overview
  28. 4.5.3 Stevanato Group Tubular Injection Vial Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Stevanato Group Tubular Injection Vial Product Portfolio
  30. 4.5.5 Stevanato Group Recent Developments
  31. 4.6 Corning
  32. 4.6.1 Corning Company Information
  33. 4.6.2 Corning Business Overview
  34. 4.6.3 Corning Tubular Injection Vial Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Corning Tubular Injection Vial Product Portfolio
  36. 4.6.5 Corning Recent Developments
  37. 4.7 Nipro Corporation
  38. 4.7.1 Nipro Corporation Company Information
  39. 4.7.2 Nipro Corporation Business Overview
  40. 4.7.3 Nipro Corporation Tubular Injection Vial Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Nipro Corporation Tubular Injection Vial Product Portfolio
  42. 4.7.5 Nipro Corporation Recent Developments
  43. 4.8 Daikyo Seiko
  44. 4.8.1 Daikyo Seiko Company Information
  45. 4.8.2 Daikyo Seiko Business Overview
  46. 4.8.3 Daikyo Seiko Tubular Injection Vial Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Daikyo Seiko Tubular Injection Vial Product Portfolio
  48. 4.8.5 Daikyo Seiko Recent Developments
  49. 4.9 West Pharmaceutical
  50. 4.9.1 West Pharmaceutical Company Information
  51. 4.9.2 West Pharmaceutical Business Overview
  52. 4.9.3 West Pharmaceutical Tubular Injection Vial Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 West Pharmaceutical Tubular Injection Vial Product Portfolio
  54. 4.9.5 West Pharmaceutical Recent Developments
  55. 4.10 Radpharm Scientific
  56. 4.10.1 Radpharm Scientific Company Information
  57. 4.10.2 Radpharm Scientific Business Overview
  58. 4.10.3 Radpharm Scientific Tubular Injection Vial Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Radpharm Scientific Tubular Injection Vial Product Portfolio
  60. 4.10.5 Radpharm Scientific Recent Developments
  61. 4.11 Pacific Vial Manufacturing
  62. 4.11.1 Pacific Vial Manufacturing Company Information
  63. 4.11.2 Pacific Vial Manufacturing Business Overview
  64. 4.11.3 Pacific Vial Manufacturing Tubular Injection Vial Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Pacific Vial Manufacturing Tubular Injection Vial Product Portfolio
  66. 4.11.5 Pacific Vial Manufacturing Recent Developments
  67. 4.12 Ningbo Zhengli Pharmaceutical Packaging
  68. 4.12.1 Ningbo Zhengli Pharmaceutical Packaging Company Information
  69. 4.12.2 Ningbo Zhengli Pharmaceutical Packaging Business Overview
  70. 4.12.3 Ningbo Zhengli Pharmaceutical Packaging Tubular Injection Vial Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Ningbo Zhengli Pharmaceutical Packaging Tubular Injection Vial Product Portfolio
  72. 4.12.5 Ningbo Zhengli Pharmaceutical Packaging Recent Developments
  73. 4.13 Linuo Pharmaceutical Packaging
  74. 4.13.1 Linuo Pharmaceutical Packaging Company Information
  75. 4.13.2 Linuo Pharmaceutical Packaging Business Overview
  76. 4.13.3 Linuo Pharmaceutical Packaging Tubular Injection Vial Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Linuo Pharmaceutical Packaging Tubular Injection Vial Product Portfolio
  78. 4.13.5 Linuo Pharmaceutical Packaging Recent Developments
  79. 4.14 Chongqing Zhengchuan Pharmaceutical Packaging
  80. 4.14.1 Chongqing Zhengchuan Pharmaceutical Packaging Company Information
  81. 4.14.2 Chongqing Zhengchuan Pharmaceutical Packaging Business Overview
  82. 4.14.3 Chongqing Zhengchuan Pharmaceutical Packaging Tubular Injection Vial Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Chongqing Zhengchuan Pharmaceutical Packaging Tubular Injection Vial Product Portfolio
  84. 4.14.5 Chongqing Zhengchuan Pharmaceutical Packaging Recent Developments
  85. 4.15 Shandong Pharmaceutical Glass
  86. 4.15.1 Shandong Pharmaceutical Glass Company Information
  87. 4.15.2 Shandong Pharmaceutical Glass Business Overview
  88. 4.15.3 Shandong Pharmaceutical Glass Tubular Injection Vial Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Shandong Pharmaceutical Glass Tubular Injection Vial Product Portfolio
  90. 4.15.5 Shandong Pharmaceutical Glass Recent Developments
  91. 4.16 CANGZHOU FOUR STARS GLASS
  92. 4.16.1 CANGZHOU FOUR STARS GLASS Company Information
  93. 4.16.2 CANGZHOU FOUR STARS GLASS Business Overview
  94. 4.16.3 CANGZHOU FOUR STARS GLASS Tubular Injection Vial Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 CANGZHOU FOUR STARS GLASS Tubular Injection Vial Product Portfolio
  96. 4.16.5 CANGZHOU FOUR STARS GLASS Recent Developments
  97. 4.17 Anhui Huaxin Pharmaceutical Glass Products
  98. 4.17.1 Anhui Huaxin Pharmaceutical Glass Products Company Information
  99. 4.17.2 Anhui Huaxin Pharmaceutical Glass Products Business Overview
  100. 4.17.3 Anhui Huaxin Pharmaceutical Glass Products Tubular Injection Vial Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Anhui Huaxin Pharmaceutical Glass Products Tubular Injection Vial Product Portfolio
  102. 4.17.5 Anhui Huaxin Pharmaceutical Glass Products Recent Developments
  103. 4.18 Jiyuan Zhengyu Industrial
  104. 4.18.1 Jiyuan Zhengyu Industrial Company Information
  105. 4.18.2 Jiyuan Zhengyu Industrial Business Overview
  106. 4.18.3 Jiyuan Zhengyu Industrial Tubular Injection Vial Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Jiyuan Zhengyu Industrial Tubular Injection Vial Product Portfolio
  108. 4.18.5 Jiyuan Zhengyu Industrial Recent Developments
  109. 4.19 Taian Youlyy Industrial
  110. 4.19.1 Taian Youlyy Industrial Company Information
  111. 4.19.2 Taian Youlyy Industrial Business Overview
  112. 4.19.3 Taian Youlyy Industrial Tubular Injection Vial Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Taian Youlyy Industrial Tubular Injection Vial Product Portfolio
  114. 4.19.5 Taian Youlyy Industrial Recent Developments
  115. 4.20 Nantong Xinde Medical Packing Material
  116. 4.20.1 Nantong Xinde Medical Packing Material Company Information
  117. 4.20.2 Nantong Xinde Medical Packing Material Business Overview
  118. 4.20.3 Nantong Xinde Medical Packing Material Tubular Injection Vial Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Nantong Xinde Medical Packing Material Tubular Injection Vial Product Portfolio
  120. 4.20.5 Nantong Xinde Medical Packing Material Recent Developments
  121. 4.21 Chengdu Jingu Medicinal Packing
  122. 4.21.1 Chengdu Jingu Medicinal Packing Company Information
  123. 4.21.2 Chengdu Jingu Medicinal Packing Business Overview
  124. 4.21.3 Chengdu Jingu Medicinal Packing Tubular Injection Vial Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Chengdu Jingu Medicinal Packing Tubular Injection Vial Product Portfolio
  126. 4.21.5 Chengdu Jingu Medicinal Packing Recent Developments
5 Global Tubular Injection Vial Market Scenario by Region
  1. 5.1 Global Tubular Injection Vial Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Tubular Injection Vial Sales by Region: 2021-2032
  3. 5.2.1 Global Tubular Injection Vial Sales by Region: 2021-2026
  4. 5.2.2 Global Tubular Injection Vial Sales by Region: 2027-2032
  5. 5.3 Global Tubular Injection Vial Revenue by Region: 2021-2032
  6. 5.3.1 Global Tubular Injection Vial Revenue by Region: 2021-2026
  7. 5.3.2 Global Tubular Injection Vial Revenue by Region: 2027-2032
  8. 5.4 North America Tubular Injection Vial Market Facts & Figures by Country
  9. 5.4.1 North America Tubular Injection Vial Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Tubular Injection Vial Sales by Country (2021-2032)
  11. 5.4.3 North America Tubular Injection Vial Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Tubular Injection Vial Market Facts & Figures by Country
  16. 5.5.1 Europe Tubular Injection Vial Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Tubular Injection Vial Sales by Country (2021-2032)
  18. 5.5.3 Europe Tubular Injection Vial Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Tubular Injection Vial Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Tubular Injection Vial Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Tubular Injection Vial Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Tubular Injection Vial Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Tubular Injection Vial Market Facts & Figures by Country
  41. 5.7.1 South America Tubular Injection Vial Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Tubular Injection Vial Sales by Country (2021-2032)
  43. 5.7.3 South America Tubular Injection Vial Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Tubular Injection Vial Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Tubular Injection Vial Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Tubular Injection Vial Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Tubular Injection Vial Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Tubular Injection Vial Sales by Type (2021-2032)
  2. 6.1.1 Global Tubular Injection Vial Sales by Type (2021-2032) & (M units)
  3. 6.1.2 Global Tubular Injection Vial Sales Market Share by Type (2021-2032)
  4. 6.2 Global Tubular Injection Vial Revenue by Type (2021-2032)
  5. 6.2.1 Global Tubular Injection Vial Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Tubular Injection Vial Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Tubular Injection Vial Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Tubular Injection Vial Sales by Application (2021-2032)
  2. 7.1.1 Global Tubular Injection Vial Sales by Application (2021-2032) & (M units)
  3. 7.1.2 Global Tubular Injection Vial Sales Market Share by Application (2021-2032)
  4. 7.2 Global Tubular Injection Vial Revenue by Application (2021-2032)
  5. 7.2.1 Global Tubular Injection Vial Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Tubular Injection Vial Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Tubular Injection Vial Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Tubular Injection Vial Value Chain Analysis
  2. 8.1.1 Tubular Injection Vial Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Tubular Injection Vial Production Mode & Process
  5. 8.2 Tubular Injection Vial Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Tubular Injection Vial Distributors
  8. 8.2.3 Tubular Injection Vial Customers
9 Global Tubular Injection Vial Analyzing Market Dynamics
  1. 9.1 Tubular Injection Vial Industry Trends
  2. 9.2 Tubular Injection Vial Industry Drivers
  3. 9.3 Tubular Injection Vial Industry Opportunities and Challenges
  4. 9.4 Tubular Injection Vial Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst